LEENA SAJ: Open Payments
NPI 1649888439 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 52 payments from 12 companies in 2025. Trend: 2023 $999 · 2024 $707 · 2025 $1,340
Food & beverage: $1,229Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $268 |
| E.R. Squibb & Sons, L.L.C. | 4 | $178 |
| Neurocrine BioSciences, Inc. | 3 | $176 |
| Vanda Pharmaceuticals Inc. | 7 | $158 |
| ABBVIE INC. | 9 | $135 |
| Lundbeck LLC | 6 | $122 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
Products named: COBENFY, INGREZZA, REXULTI, VRAYLAR, UZEDY, Auvelity, HETLIOZ, FANAPT.
Industry payments across DE — which companies pay providers there.
